PULMONX CORPORATION
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $90.5M | $83.8M | $68.7M | $53.7M | $48.4M | $32.7M | $32.6M | $20.0M |
| Cost of Revenue | $23.4M | $21.8M | $17.9M | $13.8M | $12.8M | $11.5M | $10.2M | $7.7M |
| Gross Profit | $67.1M | $62.0M | $50.8M | $39.9M | $35.6M | $21.2M | $22.4M | $12.3M |
| Gross Margin | 74.2% | 74.0% | 73.9% | 74.3% | 73.6% | 64.8% | 68.8% | 61.4% |
| Operating Expenses | ||||||||
| Research & Development | $19.5M | $17.6M | $18.1M | $15.4M | $13.1M | $7.5M | $6.0M | $7.0M |
| SG&A Expense | $101.3M | $102.1M | $94.6M | $83.1M | $69.9M | $46.1M | $34.2M | $20.3M |
| Operating Income | $-53.7M | $-57.7M | $-61.9M | $-58.6M | $-47.3M | $-32.3M | $-17.8M | $-15.1M |
| Operating Margin | -59.3% | -68.9% | -90.2% | -109.3% | -97.7% | -98.8% | -54.7% | -75.2% |
| Interest Expense | — | — | $3.2M | $1.1M | $829.0K | $3.2M | $2.3M | $2.5M |
| Pretax Income | $-53.4M | $-55.9M | $-60.3M | $-58.6M | $-48.3M | $-32.0M | $-20.3M | $-18.5M |
| Income Tax Expense | $626.0K | $500.0K | $571.0K | $353.0K | $343.0K | $213.0K | $363.0K | $12.0K |
| Net Income | $-54.0M | $-56.4M | $-60.8M | $-58.9M | $-48.7M | $-32.2M | $-20.7M | $-18.5M |
| Net Margin | -59.7% | -67.3% | -88.6% | -109.8% | -100.5% | -98.5% | -63.5% | -92.4% |
| EPS (Basic) | $-1.33 | $-1.44 | $-1.60 | $-1.59 | $-1.35 | $-0.79 | $-2.92 | $-2.76 |
| EPS (Diluted) | $-1.33 | $-1.44 | $-1.60 | $-1.59 | $-1.35 | $-0.79 | $-2.92 | $-2.76 |
| Shares Outstanding (Basic) | 40.7M | 39.1M | 38.0M | 37.1M | 36.1M | 40.7M | 8.4M | — |
| Shares Outstanding (Diluted) | 40.7M | 39.1M | 38.0M | 37.1M | 36.1M | 40.7M | 8.4M | — |
| Dividends Per Share | — | — | — | — | — | — | — | — |